Trupanion (TRUP) Received its Third Buy in a Row


After Stifel Nicolaus and Craig-Hallum gave Trupanion (NYSE: TRUP) a Buy rating last month, the company received another Buy, this time from Cowen & Co. Analyst Thomas Champion reiterated a Buy rating on Trupanion today and set a price target of $47. The company’s shares closed yesterday at $40.

According to TipRanks.com, Champion is a 4-star analyst with an average return of 16.7% and a 60.5% success rate. Champion covers the Technology sector, focusing on stocks such as Sito Mobile Ltd, Mercadolibre, and Criteo SA.

Trupanion has an analyst consensus of Strong Buy, with a price target consensus of $48.50, implying a 21.3% upside from current levels. In a report issued on July 19, Craig-Hallum also initiated coverage with a Buy rating on the stock with a $55 price target.

.

See today’s analyst top recommended stocks >>

Based on Trupanion’s latest earnings release for the quarter ending March 31, the company reported a quarterly GAAP net loss of $1.48 million. In comparison, last year the company had a net profit of $411K.

Based on the recent corporate insider activity of 47 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business segments. The Subscription Business segment involves in the monthly subscriptions of pet medical insurance.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts